Results 11 to 20 of about 38,466 (239)

Aspect of Thrombolytic Therapy: A Review [PDF]

open access: yesThe Scientific World Journal, 2014
Thrombolytic therapy, also known as clot busting drug, is a breakthrough treatment which has saved untold lives. It has been used in the clinical area to treat venous and arterial thromboembolic complaints which are a foremost cause of death.
Md. Ramjan Ali   +6 more
doaj   +2 more sources

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION

open access: yesРациональная фармакотерапия в кардиологии, 2015
History of thrombolytic therapy is shortly reflected, main trials of various thrombolytics in acute ST-segment elevation myocardial infarction (STEMI) are analyzed. Perspectives of modern thrombolytic therapy in patients with STEMI are discussed.
P. G. Kesov   +3 more
doaj   +5 more sources

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke

open access: yesChinese Medical Journal, 2017
Objective: To provide a comprehensive and latest overview of susceptibility-weighted imaging (SWI) in the application of thrombolysis in acute ischemic stroke, and to update the decision-making effect and clinical value of SWI on identifying stroke ...
Lin Li   +6 more
doaj   +2 more sources

The origin of thrombolytic therapy

open access: yesJournal of the American College of Cardiology, 1989
The origin of thrombolytic therapy is briefly reviewed. It began 40 years ago with the demonstration that the injection into patients of a partially purified activator of the native plasminogen-plasmin enzyme system was capable of dissolving clotted blood and fibrinous loculations in the chest.
Sol Sherry, Sherry, Sol
openaire   +3 more sources

Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region

open access: yesРациональная фармакотерапия в кардиологии, 2018
Aim. To study data on prehospital thrombolytic therapy in ST elevation myocardial infarction (STEMI) in the Perm Krai, its efficacy and safety.Material and methods.
S. A. Naumov, N. S. Karpunina
doaj   +3 more sources

Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?

open access: yesCurrent Controlled Trials in Cardiovascular Medicine, 2000
Thrombolysis and primary angioplasty are both recommended reperfusion strategies for elderly patients presenting with myocardial infarction (MI). Primary angioplasty is most beneficial in high-risk patients. While the elderly have a high absolute risk of
White Harvey D
doaj   +2 more sources

Development of a decision analytic model to support decision making and risk communication about thrombolytic treatment [PDF]

open access: yes, 2015
Background Individualised prediction of outcomes can support clinical and shared decision making. This paper describes the building of such a model to predict outcomes with and without intravenous thrombolysis treatment following ischaemic stroke ...
Ford, Gary   +14 more
core   +1 more source

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials [PDF]

open access: yes, 2009
<p><b>Background and Purpose:</b> A number of factors have been associated with postthrombolysis intracerebral hemorrhage, but these have varied across studies.</p> <p><b>Methods:</b> We examined patients with
Demchuk, A.   +8 more
core   +1 more source

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone   +8 more
wiley   +1 more source

Thrombolytic therapy for haemodialysis catheter dysfunction–value for money?

open access: yes, 2020
Many dialysis patients rely on tunneled central venous catheters for long-term vascular access. Hemodialysis catheter dysfunction (HCD) caused by intraluminal thrombosis is a common problem often necessitating replacement.
Kurtkoti, Jagadeesh   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy